ACTRN12622000493741已完成未知
Exertional dyspnoea and exercise intolerance in pulmonary arterial hypertension: the role of skeletal muscle afferents (sub-study one)
niversity of Auckland0 个研究点目标入组 28 人开始时间: 2022年3月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with Group 1 PAH as per 6th World Symposium on Pulmonary Hypertension
- •Exertional dyspnoea (WHO functional class II and III)
- •Control participants free from PAH, age and sex-matched with no known health conditions
- •Men and women
- •Aged 18 years or over
排除标准
- •Group 2, 3, 4, 5 pulmonary hypertension
- •Six minute walk distance < 300m
- •Dyspnoea at rest (WHO functional class IV)
- •Significant left ventricular dysfunction (Left ventricular ejection fraction <40% or significant diastolic dysfunction)
- •Obstructive or restrictive lung disease
- •oPulmonary fibrosis or emphysema on chest radiograph or computed tomography scan
- •oTotal lung capacity <80% of predicted
- •oForced expiratory volume in first second of expiration/ forced vital capacity <70%
- •oCurrently taking regular inhaled therapy for airways disease
- •Serious co-morbidities that may contribute to dyspnoea and/or reduce exercise capacity including:
- •oSevere cardiac disease (e.g., heart failure, coronary artery disease)
- •oSevere respiratory disease other than PAH (e.g., chronic obstructive pulmonary disease, interstitial lung disease)
- •oSevere obesity (Body mass index > 35 kg/m2)
- •oSevere orthopaedic impairment or rheumatologic/ connective tissue disease
- •oSignificant neurological disease
- •oSignificant renal or liver disease
- •oInfection or pyrexial illness
- •oUncontrolled thyroid disorders
- •oCurrent active treatment for cancer
- •Presence of any contraindications to cardiopulmonary exercise testing
- •oUnstable angina or recent acute myocardial infarction
- •oUncontrolled arrhythmias causing symptoms or haemodynamic compromise
- •oSymptomatic severe aortic stenosis
- •oOxygen saturation <85% at rest on room air
- •oUncontrolled heart failure
- •oUncontrolled asthma
- •oUncontrolled thyroid disorders
- •oMental impairment leading to inability to cooperate
- •oLong-term oxygen therapy
- •Current pregnancy
- •Current users of recreational drugs
- •Current abusers of alcohol
- •Inability to fully or appropriately provide consent (e.g., language issue, reading capability)
- •Underlying medical conditions, which in the opinion of the Investigator place the participant at unacceptably high risk for participating in the study.
研究者
相似试验
尚未招募
不适用
Exertional breathlessness in pulmonary arterial hypertensioPulmonary arterial hypertensionACTRN12622000494730niversity of Auckland15
已完成
4 期
Exertional breathlessness in pulmonary arterial hypertensioPulmonary arterial hypertensionACTRN12622000505707niversity of Auckland9
招募中
4 期
nderstanding breathlessness in interstitial lung diseaseInterstitial Lung diseaseACTRN12621000049875niversity of Auckland15
招募中
4 期
nderstanding breathlessness in interstitial lung diseaseRespiratory - Other respiratory disorders / diseasesInterstitial Lung diseaseACTRN12621000454875niversity of Auckland15
已完成
不适用
nderstanding breathlessness in interstitial lung diseaseRespiratory - Other respiratory disorders / diseasesInterstitial Lung DiseaseACTRN12620001018909niversity of Auckland32